✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Ishita Drugs & Industries Ltd.

ISHITADR

Market Cap
₹23 Cr.
P/E
27.26

Ishita Drugs & Industries Ltd.

  • Ishita Drugs & Inds.
  • Adeshwar Meditex
  • Phaarmasia
FAQs on Ishita Drugs & Industries Ltd. Shareprice

Ishita Drugs & Inds. has given better returns compared to its competitors.
Ishita Drugs & Inds. has grown at ~15.65% over the last 3yrs while peers have grown at a median rate of 2.0%

Yes, Ishita Drugs & Inds. is expensive.
Latest PE of Ishita Drugs & Inds. is 27.26, while 3 year average PE is 23.39.
Also latest EV/EBITDA of Ishita Drugs & Inds. is 18.71 while 3yr average is 15.32.

View FAQ's On Business
Growth Table
  • Ishita Drugs & Industries Ltd.
  • Adeshwar Meditex
  • Phaarmasia
Balance Sheet
  • Ishita Drugs & Industries Ltd.
  • Adeshwar Meditex
  • Phaarmasia
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ishita Drugs & Industries Ltd.
  • Adeshwar Meditex
  • Phaarmasia
Cash Flow
  • Ishita Drugs & Industries Ltd.
  • Adeshwar Meditex
  • Phaarmasia
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ishita Drugs & Industries Ltd.
  • Adeshwar Meditex
  • Phaarmasia
Quarterly Results
  • Ishita Drugs & Industries Ltd.
  • Adeshwar Meditex
  • Phaarmasia
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Ishita Drugs & Industries Ltd. Financials

Balance sheet of Ishita Drugs & Inds. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Ishita Drugs & Inds. is increasing.
Latest debt of Ishita Drugs & Inds. is -₹4.22 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹9.25 Crs.

Yes, profit is increasing.
The profit of Ishita Drugs & Inds. is ₹0.86 Crs for TTM, ₹0.75 Crs for Mar 2024 and ₹0.58 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ishita Drugs & Inds. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech